Cargando…

The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy

BACKGROUND: This study shows the results of a regional pharmacovigilance program on Natalizumab therapy in relapsing-remitting multiple sclerosis (RR-MS) patients after 3 years of experience. MATERIAL/METHODS: The primary objectives of this study were to estimate the incidence of expected and unexpe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giacoppo, Sabrina, Ruscica, Maria, Grimaldi, Luigi Maria, Bramanti, Placido, Mazzon, Emanuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592973/ https://www.ncbi.nlm.nih.gov/pubmed/28864818 http://dx.doi.org/10.12659/MSM.903301

Ejemplares similares

Topical moringin cream relieves neuropathic pain by suppression of inflammatory pathway and voltage-gated ion channels in murine model of multiple sclerosis
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson’s disease: involvement of the PI3K/Akt/mTOR pathway
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
por: Maria, Galuppo, et al.
Publicado: (2014)

Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis
por: Soundara Rajan, Thangavelu, et al.
Publicado: (2017)

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
por: Giacoppo, Sabrina, et al.
Publicado: (2014)

Administration of 4-(α-L-Rhamnosyloxy)-benzyl Isothiocyanate Delays Disease Phenotype in SOD1(G93A) Rats: A Transgenic Model of Amyotrophic Lateral Sclerosis
por: Galuppo, Maria, et al.
Publicado: (2015)

Identification of CD4(+) T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment
por: Fagone, Paolo, et al.
Publicado: (2019)

Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

Moringa isothiocyanate complexed with α-cyclodextrin: a new perspective in neuroblastoma treatment
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

Retraction Note: Moringa isothiocyanate complexed with α-cyclodextrin: a new perspective in neuroblastoma treatment
por: Giacoppo, Sabrina, et al.
Publicado: (2023)

A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
por: Giacoppo, Sabrina, et al.
Publicado: (2015)

The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
por: Libro, Rosaliana, et al.
Publicado: (2016)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
por: Giacoppo, Sabrina, et al.
Publicado: (2016)

Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

Tuscan black kale sprout extract bioactivated with myrosinase: a novel natural product for neuroprotection by inflammatory and oxidative response during cerebral ischemia/reperfusion injury in rat
por: Giacoppo, Sabrina, et al.
Publicado: (2015)

Could the Heat Shock Proteins 70 Family Members Exacerbate the Immune Response in Multiple Sclerosis? An in Silico Study
por: Chiricosta, Luigi, et al.
Publicado: (2020)

Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017)

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017)

Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials
por: Schepici, Giovanni, et al.
Publicado: (2019)

Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis
por: Trubiani, Oriana, et al.
Publicado: (2016)

Cannabinoid CB2 Receptors are Involved in the Protection of RAW264.7 Macrophages Against the Oxidative Stress: An in Vitro Study
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

Moringin activates Wnt canonical pathway by inhibiting GSK3β in a mouse model of experimental autoimmune encephalomyelitis
por: Giacoppo, Sabrina, et al.
Publicado: (2016)

Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
por: Gugliandolo, Agnese, et al.
Publicado: (2019)

Natalizumab in the pediatric MS population: results of the Italian registry
por: Ghezzi, Angelo, et al.
Publicado: (2015)

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
por: Mammana, Santa, et al.
Publicado: (2018)

A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis
por: Trojano, Maria, et al.
Publicado: (2021)

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
por: Butzkueven, Helmut, et al.
Publicado: (2014)

Interferons and Natalizumab for Multiple Sclerosis
por: Clar, Christine, et al.
Publicado: (2008)

Natalizumab in the treatment of multiple sclerosis
por: Brown, Brandon A
Publicado: (2009)

The use of natalizumab for multiple sclerosis
por: Brandstadter, Rachel, et al.
Publicado: (2017)

Natalizumab Rebound in Multiple Sclerosis
por: Lee, Joshua D., et al.
Publicado: (2021)

The secretome of periodontal ligament stem cells from MS patients protects against EAE
por: Rajan, Thangavelu Soundara, et al.
Publicado: (2016)

Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry
por: Prosperini, Luca, et al.
Publicado: (2016)

Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study
por: Fernández, O., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0ivo5j43p9lvbjt7t31uojtd9q